A Phase 2 Study of Tasisulam Sodium (LY573636 Sodium) as Second-Line Treatment for Patietns With Unresectable or Metastatic Melanoma

J.M. Kirkwood, R. Gonzalez, D. Reintgen, P.R. Clingan, R.R. Mcwilliams, D.P. De Alwis, A. Zimmerman, M.P. Brown, R.L. Ilaria, Michael Millward

    Research output: Contribution to journalArticlepeer-review

    19 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)4732-9
    JournalCancer
    Volume117
    DOIs
    Publication statusPublished - 2011

    Cite this